ForViva (LON:FVA – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Shore Capital Group in a report issued on Wednesday, Digital Look reports. They currently have a GBX 135 target price on the stock. Shore Capital Group’s price objective points to a potential downside of 10.00% from the company’s previous close.
Separately, Canaccord Genuity Group restated a “buy” rating and issued a GBX 190 target price on shares of ForViva in a research note on Friday, August 14th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 162.50.
Check Out Our Latest Stock Report on ForViva
ForViva Trading Up 2.0%
Insider Buying and Selling at ForViva
In related news, insider Tim Jones purchased 40,000 shares of the firm’s stock in a transaction dated Friday, July 17th. The stock was bought at an average price of GBX 138 per share, for a total transaction of £55,200. Insiders bought a total of 90,000 shares of company stock valued at $12,380,000 over the last ninety days. 7.31% of the stock is owned by insiders.
ForViva Company Profile
ForViva plc (LON: FVA) is a United Kingdom–based property company that operates in the residential and specialist housing sectors. The group’s activities are focused on ownership, management and leasing of housing assets that serve social, affordable and supported living needs. Its portfolio is oriented toward providing long?term rental accommodation and specialist premises that accommodate people requiring additional care or support.
Services associated with ForViva’s property portfolio typically include day?to?day asset management, tenancy management, property maintenance and refurbishment, and collaboration with public sector bodies and third?party care providers to deliver supported housing solutions.
See Also
- Five stocks we like better than ForViva
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for ForViva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ForViva and related companies with MarketBeat.com's FREE daily email newsletter.
